810158C
Avanti
16:0 Liss Rhod PE
Avanti Research™ - A Croda Brand 810158C
동의어(들):
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt)
로그인조직 및 계약 가격 보기
모든 사진(2)
About This Item
실험식(Hill 표기법):
C64H105N4O14PS2
CAS Number:
Molecular Weight:
1249.64
MDL number:
UNSPSC 코드:
12352211
NACRES:
NA.25
추천 제품
분석
>99% (TLC)
양식
liquid
포장
pkg of 1 × 1 mL (810158C-1mg)
pkg of 5 × 1 mL (810158C-5mg)
제조업체/상표
Avanti Research™ - A Croda Brand 810158C
농도
1 mg/mL (810158C-1mg)
1 mg/mL (810158C-5mg)
배송 상태
dry ice
저장 온도
−20°C
일반 설명
16:0 Liss Rhod PE is a fluorescent phospholipid.
애플리케이션
16:0 Liss Rhod PE has been used in the preparation of lipid-oil mixtures for fluorescent imaging and as a tracer lipid in process of unilamellar vesicles production. It is also suitable for fluorescent visualization of the phospholipids in tribiological investigation.
포장
5 mL Amber Glass Screw Cap Vial (810158C-1mg)
5 mL Amber Glass Screw Cap Vial (810158C-5mg)
법적 정보
Avanti Research is a trademark of Avanti Polar Lipids, LLC
신호어
Danger
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
표적 기관
Central nervous system, Liver,Kidney
Storage Class Code
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
WGK
WGK 3
Flash Point (°F)
does not flash
Flash Point (°C)
does not flash
가장 최신 버전 중 하나를 선택하세요:
이미 열람한 고객
Tribological Analysis of UHMWPE Tibial Implants in Unicompartmental Knee Replacements: From Retrieved to In Vitro Studies
Sava MM, et al.
BioTechnology: An Indian Journal, 13, 1-15 (2018)
Dynamic morphologies of microscale droplet interface bilayers
Mruetusatorn P, et al.
Soft Matter, 10(15), 2530-2538 (2014)
Three dimensional (temperature-tension-composition) phase map of mixed DOPC-DPPC vesicles: Two solid phases and a fluid phase coexist on three intersecting planes
Chen D, et al.
Biochimica et Biophysica Acta - Biomembranes, 1838(11), 2788-2797 (2014)
Madi El-Haj et al.
Immunologic research, 67(4-5), 337-347 (2019-11-23)
The considerable variability of responses amongst subjects to disease triggers and immunotherapies is a major obstacle to designing better immune-based therapies. Therefore, development of patient-tailored precision medicine that improves the efficacy of immunomodulatory drugs is necessary. The individualized response to
Hamed Hamedinasab et al.
International journal of biological macromolecules (2019-11-27)
The purpose of the present investigation was to formulate NAC (N-acetylcysteine)-loaded chitosan (CH)-coated liposome aiming at obtaining an effective formulation able to ensure a prolonged and controlled release of NAC to the lung by inhalation. Empty liposomes [(DPPG/Chol/DPPG with different
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.